Point72 Hong Kong LTD Biomea Fusion, Inc. Call Options Transaction History
Point72 Hong Kong LTD
- $1.5 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BMEA
# of Institutions
109Shares Held
16.1MCall Options Held
229KPut Options Held
354K-
Cormorant Asset Management, LP Boston, MA3.57MShares$6.43 Million0.81% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$4.22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$2.48 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$1.44 Million0.59% of portfolio
-
Geode Capital Management, LLC Boston, MA626KShares$1.13 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $52.7M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...